weight loss shutter2

What’s Going On With Amgen Stock On Friday?

On Friday, Novo Nordisk A/S (NYSE:NVO) released headline results from the REDEFINE 1 Phase 3 trial in the global REDEFINE program.When evaluating the effects of treatment if all people adhered to treatment, people treated with CagriSema achieved a weight loss of 22.7% after 68 weeks compared to a reduction of 11.8% with cagrilintide 2.4 mg, […]

Read More
blur 1853262

Why Nasdaq-100 Inverse ETF SQQQ Is Moving

ProShares UltraPro Short QQQ (NASDAQ:SQQQ), which offers leveraged inverse exposure to the Invesco QQQ Trust, Series 1 (NASDAQ:QQQ), gained 3% to $28.95 Wednesday afternoon as the Federal Reserve delivered a dovish tone during its December meeting.SQQQ, designed to rise when the Nasdaq-100 falls, benefits from bearish sentiment toward growth-oriented technology stocks.What Happened: The Fed lowered […]

Read More